Anticoagulation in Stent Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 304 participants.

Also called NCT01141153

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 304 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01141153
  • EudraCT 2009-017256-27
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01141153. Randomized; single masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anticoagulation in Stent Intervention
Acronym
MUSICA-2
Condition
Stroke
Intervention (Drug)
Acetylsalicylic Acid + clopidogrel + acenocoumarol
Intervention (Drug)
Acetylsalicylic Acid + clopidogrel
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute (class: other)

Record details

Record id
cardio:ct-nct01141153
Content hash
ee4a040d75d97335231bf6f6dc5608d19473b47368d3d5386801ddc1ebede44b